AXT Inc (AXTI) director sells 2,500 company shares
Rhea-AI Filing Summary
AXT INC (AXTI) director Leonard J. LeBlanc reported open-market or private sales of the company’s common stock. He sold 2,000 shares on 2026-08-07 at an average price of $88.315 per share and 500 shares on 2026-06-10 at $89.59 per share, totaling 2,500 shares sold. The filing indicates these transactions were not made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 2,500 shares
Net Sell
2 txns
Insider
LEBLANC LEONARD J
Role
Director
Sold
2,500 shs ($221K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,000 | $88.315 | $177K |
| Sale | Common Stock | 500 | $89.59 | $45K |
Holdings After Transaction:
Common Stock — 117,129 shares (Direct)
Key Figures
Shares sold on 2026-08-07: 2000 shares
Sale price on 2026-08-07: $88.315 per share
Shares sold on 2026-06-10: 500 shares
+2 more
5 metrics
Shares sold on 2026-08-07
2000 shares
Non-derivative sale of AXTI common stock by director Leonard J. LeBlanc
Sale price on 2026-08-07
$88.315 per share
Average price for 2,000 AXTI shares sold
Shares sold on 2026-06-10
500 shares
Non-derivative sale of AXTI common stock by director Leonard J. LeBlanc
Sale price on 2026-06-10
$89.59 per share
Average price for 500 AXTI shares sold
Total shares sold in filing
2500 shares
Aggregate of both reported AXTI common stock sales
Key Terms
Form 4, non-derivative, Rule 10b5-1 trading plan, open market or private transaction
4 terms
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
non-derivative financial
"the transaction_type is listed as "non-derivative""
Rule 10b5-1 trading plan regulatory
"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open market or private transaction financial
"transaction_code_description: "Sale in open market or private transaction""
FAQ
What insider transactions did AXTI director Leonard J. LeBlanc report in this Form 4?
Leonard J. LeBlanc reported selling 2,500 AXTI common shares in two transactions. He sold 2,000 shares at $88.315 on August 7, 2026, and 500 shares at $89.59 on June 10, 2026, in open-market or private transactions.
What was the earlier AXTI stock sale reported by Leonard J. LeBlanc in June 2026?
On June 10, 2026, Leonard J. LeBlanc sold 500 shares of AXTI common stock. This non-derivative sale was executed at an average price of $89.59 per share and is also characterized as a sale in an open market or private transaction.
Were Leonard J. LeBlanc’s AXTI stock sales made under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox is not marked, so these AXTI stock sales were not affirmed as made under a Rule 10b5-1 trading plan. They are reported simply as open-market or private transactions without plan status.
Does the Form 4 disclose Leonard J. LeBlanc’s AXTI holdings after these sales?
The Form 4 does not report a post-transaction share balance for Leonard J. LeBlanc; the “shares following transaction” field is left blank for both trades. Only the fact of the 2,500 total shares sold and the per-share prices is disclosed.
AI-generated analysis. How Rhea-AI works. Not financial advice.